IMR Press / CEOG / Volume 49 / Issue 11 / DOI: 10.31083/j.ceog4911242
Open Access Editorial
Personalized Treatment of Vulvar Cancer
Show Less
1 Department of Medical and Surgical Sciences and Translational Medicine, PhD Course in “Translational Medicine and Oncology'', Sapienza University, 00185 Rome, Italy
2 Gynecologic Oncology Unit, Women Wealth Area, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
3 Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Unit Institute, 00144 Rome, Italy
4 Unit of Gynecologic Oncology, ARNAS “Civico – Di Cristina – Benfratelli'', Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90133 Palermo, Italy
*Correspondence: andrea.giannini@uniroma1.it (Andrea Giannini)
Academic Editor: Michael H. Dahan
Clin. Exp. Obstet. Gynecol. 2022, 49(11), 242; https://doi.org/10.31083/j.ceog4911242
Submitted: 10 August 2022 | Revised: 14 August 2022 | Accepted: 23 August 2022 | Published: 28 October 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Share
Back to top